Synthesis and anti-HIV activities of bis-(cycloSaligenyl) pronucleotides derivatives of 3′-fluoro-3′-deoxythymidine and 3′-azido- 3′-deoxythymidine

Tetrahedron Letters

Volumn 52, Issue 7, 2011, Pages 802-805

  Ahmadibeni, Yousef ^a,b   Tiwari, Rakesh ^a   Swepson, Chelsie ^c   Pandhare, Jui ^c   Dash, Chandravanu ^c   Doncel, Gustavo F ^d   Parang, Keykavous ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b University System of Georgia   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Anti HIV; AZT; Bis (cycloSaligenyl); FLT; Nucleosides

Indexed keywords

3' FLUOROTHYMIDINE; BIS (CYCLOSALIGENYL) DIPHOSPHATE TRIESTER; MOLECULAR SCAFFOLD; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; OXIDATION;

EID: 78651412357     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.12.038     Document Type: Article

References (23)

1. J. Balzarini Pharm. World Sci. 16 1994 113 126
2. V.L. Damaraju, S. Damaraju, J.D. Young, S.A. Baldwin, J. Mackey, M.B. Sawyer, and C.E. Cass Oncogene 22 2003 7524 7536
3. E. De Clercq Nat. Rev. Drug Discovery 1 2002 13 25
4. P. Herdewijn, J. Balzarini, and E. De Clercq 2′,3′- Dideoxynucleoside Analogues as Anti-HIV Agents E. De Clercq, Advances Antiviral Drug Design Vol. 1 1993 JAI Press Inc. Greenwich, London 233 318
5. J.P. Van Roey, E.W. Taylor, C.K. Chu, and R.F. Shinazi Ann. N. Y. Acad. Sci. 616 1990 29 40
6. J. Balzarini, P. Heredewijn, and E. De Clercq J. Biol. Chem. 264 1989 6127 6133
7. K. Parang, L.I. Wiebe, and E.E. Knaus Curr. Med. Chem. 7 2000 995 1039
8. C. Meier Synlett 1998 233 242
9. C.R. Wagner, V.V. Lyer, and E.J. McIntee Med. Res. Rev. 20 2000 417 451
10. C. Perigaud, G. Gosselin, and J.L. Imbach P.F. Torrence, Biomedical Chemistry/Applying Chemical Principles to the Understanding and Treatment of Disease Vol. 55 2000 John Wiley & Sons New York 115 141
11. C. Meier Eur. J. Org. Chem. 2006 1081 1102
12. C. Meier E. De Clercq, Advances Antiviral Drug Design Vol. 4 2004 Elsevier Amsterdam 147 213
13. C. Meier Mini-Rev. Med. Chem. 2 2002 219 234
14. C. Meier, A. Meerbach, and J. Balzarini Front. Biosci. 9 2004 873 890
15. J. Balzarini, S. Aquaro, T. Knispel, C. Rampazzo, V. Bianchi, C.F. Perno, E. De Clercq, and C. Meier Mol. Pharmacol. 58 2000 928 935
16. C. Meier, C. Ducho, H. Jessen, D. Vukadinovic-Tenter, and J. Balzarini Eur. J. Org. Chem. 2006 197 206
17. C. Meier, J. Renze, C. Ducho, and J. Balzarini Curr. Top. Med. Chem. 2 2002 1111 1121
18. S.J. Hecker, and M.D. Erion J. Med. Chem. 51 2008 2328 2345
19. S. Freeman, and K.C. Ross Prog. Med. Chem. 34 1997 111 147
20. C. Ducho, U. Görbig, S. Jessel, N. Gisch, J. Balzarini, and C. Meier J. Med. Chem. 50 2007 1335 1346
21. N. Gisch, J. Balzarini, and C. Meier J. Med. Chem. 52 2009 3464 3473
22. F.C. Krebs, S.R. Miller, D. Malamud, M.K. Howett, and B. Wigdahl Antiviral Res. 43 1999 157 173
23. H.K. Agarwal, G.F. Doncel, and K. Parang Tetrahedron Lett. 49 2008 4905 4907